Search by Drug Name or NDC

    NDC 55150-0348-10 NEOSTIGMINE METHYLSULFATE 0.5 mg/mL Details

    NEOSTIGMINE METHYLSULFATE 0.5 mg/mL

    NEOSTIGMINE METHYLSULFATE is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eugia US LLC. The primary component is NEOSTIGMINE METHYLSULFATE.

    Product Information

    NDC 55150-0348
    Product ID 55150-348_c5729883-88d7-40fe-8fe4-fe39204ccb30
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name NEOSTIGMINE METHYLSULFATE
    Proprietary Name Suffix n/a
    Non-Proprietary Name NEOSTIGMINE METHYLSULFATE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAVENOUS
    Active Ingredient Strength 0.5
    Active Ingredient Units mg/mL
    Substance Name NEOSTIGMINE METHYLSULFATE
    Labeler Name Eugia US LLC
    Pharmaceutical Class Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA213244
    Listing Certified Through 2024-12-31

    Package

    NDC 55150-0348-10 (55150034810)

    NDC Package Code 55150-348-10
    Billing NDC 55150034810
    Package 10 VIAL, MULTI-DOSE in 1 CARTON (55150-348-10) / 10 mL in 1 VIAL, MULTI-DOSE (55150-348-01)
    Marketing Start Date 2023-11-02
    NDC Exclude Flag N
    Pricing Information N/A